AU Patent

AU2016304420A1 — Crystalline form of lorlatinib free base

Assigned to Pfizer Inc · Expires 2018-02-01 · 8y expired

What this patent protects

This invention relates to acrystalline form of (10

USPTO Abstract

This invention relates to acrystalline form of (10

Drugs covered by this patent

Patent Metadata

Patent number
AU2016304420A1
Jurisdiction
AU
Classification
—
Expires
2018-02-01
Drug substance claim
No
Drug product claim
No
Assignee
Pfizer Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.